HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yongqian Jia Selected Research

Yongqian Jia Research Topics

Disease

4Leukemia
01/2022 - 12/2015
3Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
12/2021 - 06/2013
3Neoplasms (Cancer)
12/2021 - 08/2017
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2020 - 12/2015
2Autoimmune Diseases (Autoimmune Disease)
04/2020 - 06/2013
2Hodgkin Disease (Hodgkin's Disease)
01/2018 - 09/2017
1Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
03/2022
1Graft vs Host Disease (Graft-Versus-Host Disease)
01/2021
1Primary Myelofibrosis (Myelosclerosis)
01/2021
1Ankylosing Spondylitis
04/2020
1Lymphoma (Lymphomas)
08/2017
1T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic)
06/2015
1Interstitial Lung Diseases (Interstitial Lung Disease)
06/2013
1B-Cell Lymphoma (Lymphoma, B Cell)
06/2013
1Respiratory Insufficiency (Respiratory Failure)
06/2013
1Type 2 Diabetes Mellitus (MODY)
12/2008

Drug/Important Bio-Agent (IBA)

3N- (2- amino- 5- fluorobenzyl)- 4- (N- (pyridine- 3- acrylyl)aminomethyl)benzamideIBA
01/2021 - 09/2017
3DecitabineFDA Link
12/2019 - 09/2017
2Rituximab (Mabthera)FDA Link
03/2022 - 06/2013
2Biomarkers (Surrogate Marker)IBA
04/2020 - 01/2020
2Metformin (Glucophage)FDA LinkGeneric
12/2015 - 12/2008
1Prednisone (Sone)FDA LinkGeneric
03/2022
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
03/2022
1Vincristine (Oncovin)FDA LinkGeneric
03/2022
1Lenalidomide (CC 5013)FDA Link
03/2022
1Bendamustine HydrochlorideFDA Link
03/2022
1artemisinin (artemisinine)IBA
12/2021
1ArtesunateIBA
12/2021
1Antineoplastic Agents (Antineoplastics)IBA
12/2021
1Syntex adjuvant formulationIBA
01/2021
1ruxolitinibIBA
01/2021
1Deoxyribonucleases (DNase)FDA Link
04/2020
1Small Interfering RNA (siRNA)IBA
01/2020
1Cyclin D1IBA
01/2020
1Long Noncoding RNAIBA
01/2020
1Histone Acetyltransferases (Histone Acetyltransferase)IBA
09/2017
1Cell-Free Nucleic AcidsIBA
08/2017
1Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
12/2015
1Sorafenib (BAY 43-9006)FDA Link
12/2015
1Alemtuzumab (Campath)FDA Link
06/2015
1CytokinesIBA
06/2013
1Monoclonal AntibodiesIBA
06/2013

Therapy/Procedure

3Drug Therapy (Chemotherapy)
03/2022 - 06/2013
3Hematopoietic Stem Cell Transplantation
01/2021 - 06/2015
2Therapeutics
03/2022 - 01/2021
1Transplantation
01/2022
1Aftercare (After-Treatment)
01/2021
1Stem Cell Transplantation
01/2021